What Will Happen to Novartis Cholesterol Drug?
Novartis drug inclisiran wasn’t reviewed on time by the FDA—largely because of COVID-19 travel restrictions. Now, the company seeks to [...]
Yes–Prescription Costs are Much Higher in the United States
According to a recent article, there are serious discrepancies in drug prices between the United States and many other countries. [...]
Article Highlights Healthcare Challenges for Biden
A recent publication highlights ongoing issues in healthcare, along with strategies for addressing these issues for the newly elected administration. [...]
Progress with Gene Therapies Requires Medicare Reform
Novel therapeutic approaches, although promising in the personalized medicine space, remain hampered by cost issues when it comes to Medicare [...]
Conversation with Aetion Chief Legal and Executive Officer Provides Insight
Lowell Schiller, J.D., now the Chief Legal and Executive Officer at Aetion, discussed his views on RWE, the FDA, and [...]
COVID-19 Prompts RWE Discussion
During the 2020 Aetion Summit, invited speaker Amy Abernathy, MD, PHD, was invited to give her perspective on real world [...]
Data Analytics Company Artemis Health Collects Employee Data
Artemis Health surveyed employees regarding their healthcare goals at hundreds of companies. Many employees rated focusing on their health as [...]
Understanding Machine Learning Tools that Will Impact Healthcare
Predictive machine learning tools are expected to help healthcare payers and providers make cost-effective choices. However, despite being powerful tools, [...]
New Robust Tool STaRT-RWE Brings Clarity
In a recent publication, Wang et al. discuss STaRT-RWE: a tool for reporting real world evidence data. This tool is [...]
Will Pharma Prices Increase Under Biden Administration?
Pharma companies are preparing for changes under the Biden administration, including in-depth discussions about drug pricing—for both new drugs and [...]
Pharma Companies Silently Raising Prices
Many pharmaceutical companies have been rapidly increasing prices of their drugs. In only one month of 2021, more drug prices [...]
$559 Million Saved in Medicare Costs by NAACOS
According to a recent NAACOS (the National Association of ACOs) report detailing Medicare savings, over $550 million was saved by [...]
ISMPP Takes Over MPIP Leadership
ISMPP revealed it would be taking over leadership responsibilities for MPIP (Medical Publishing Insights & Practices). MPIP has been an [...]
Can the Fauci Effect Lead to a Larger Pool of Health Care Workers?
In 2020, there were 18% more medical-school-ready applicants than in previous years. This higher number is due to several factors, [...]
Bayesian Models are Underused yet Powerful Tools
In a recent study, Cytel researchers discussed the benefits of Bayesian models. They’re a good choice for both single arm [...]
2021 Brings Changes for Payers and Providers
COVID-19 has broadly impacted the healthcare system. Many fee for service providers were forced to switch to value-based payments over [...]
Online Healthcare Pricing Information Unclear and Confusing
Healthcare systems and hospitals posted pricing information for their services beginning January 1st. However, consistency across hospital systems remains lacking. [...]
ICER Releases Draft Evidence Report on Therapies for Lupus Nephritis
Also this morning, we published our Draft Evidence Report assessing the comparative clinical effectiveness and value of voclosporin (Aurinia Pharmaceuticals) [...]
ICER Publishes Evidence Report on Therapies for High Cholesterol
This morning ICER issued the Evidence Report assessing the comparative clinical effectiveness and value of inclisiran (Novartis), bempedoic acid (Nexletol®, [...]
Drug price hikes without new evidence upped spending by $1.2B
The Institute for Clinical and Economic Review (ICER) published its second-ever report on Unsupported Price Increases (UPI) last week, compiled from data [...]
Value-Based Purchasing Rule For Medicaid Rx Drugs
Writing in Health Affairs, outgoing CMS Administrator Seema Verma touts how the Trump Administration helped paved the way for more [...]
New Program in Pharmaceutical Value Assessment and Communications Launched by University of Florida
The University of Florida (UF) College of Pharmacy’s online graduate program in pharmaceutical outcomes and policy today announced the launch [...]
How Will the Role of Medical Communication Professionals Evolve by 2025?
As a new year begins, this article dives deeper into 5 areas that global contributors identified when asked, “How will [...]
AMCP Executive Fellowship in Health Care Association Leadership
In January 2021, AMCP launched the Executive Fellowship in Health Care Association Leadership. This immersive, year-long training program provides a [...]
Democrats Have Their Best Shot Yet at Letting Medicare Negotiate Drug Prices
Democrats have their best shot in more than a decade to deliver on one of the party’s central health care [...]